
A depot injection, also known as a long-acting injectable (LAI), is a term for an
injection formulation of a medication which
releases slowly over time to permit less frequent administration of a medication. They are designed to increase
medication adherence and
consistency, especially in patients who commonly forget to take their medicine. Depot injections can be created by modifying the drug molecule itself, as in the case of
prodrugs, or by modifying the way it is administered, as in the case of oil/lipid suspensions. Depot injections can have a duration of action of one month or greater and are available for many types of drugs, including
antipsychotics and
hormone
A hormone (from the Ancient Greek, Greek participle , "setting in motion") is a class of cell signaling, signaling molecules in multicellular organisms that are sent to distant organs or tissues by complex biological processes to regulate physio ...
s.
Purpose
Depot injections provide longer duration drug action through slow absorption into the bloodstream. They are usually administered
in the muscle,
into the skin, or
under the skin. The injected medication slowly releases the medication into the bloodstream. It may be used in patients who forget to take their medication; some doctors and patients consider the use of a depot injection to be coercion, and are opposed to their use for that reason.
Mechanism
Drugs may be modified to be slowly activated by the body, or be absorbed slowly by the body. Many are dissolved in an organic oil, as the compound is
lipophilic due to the addition of functional groups to provide slow action. An example of this is adding a functional group such as
decanoate.
The combination of an oil base and modification to decrease metabolic activation prevent medications from being fully released.
This can result in length of activity of 2–4 weeks or more.
The alteration of the
pharmacokinetics of the drug (the absorption and activation) does not change the side effect profile of the medication; thus,
atypical antipsychotics are still preferred over
typical antipsychotics.
Discovery
The first long-acting (depot) injections were antipsychotics
fluphenazine and
haloperidol.
The concept of a depot injection arose before 1950, and originally was used to describe antibiotic injections that lasted longer to allow for less frequent administration.
Pharmacokinetics

Most commonly, depot injections are designed to have a duration of 2–4 weeks of action,
however the pharmacokinetics of a specific formulation vary. Absorption and metabolism can both be affected by modifying the drug itself (for example, by attaching a
functional group
In organic chemistry, a functional group is any substituent or moiety (chemistry), moiety in a molecule that causes the molecule's characteristic chemical reactions. The same functional group will undergo the same or similar chemical reactions r ...
) or by the formulation of the product (examples are oil or
microsphere preparations).
Repeated administration of depot injections can lead to a half life over one month (as in some preparations of
fluphenazine), but this can be variable in different patients.
Hormonal depot injections of
estradiol can last anywhere from one week to over one month.
Medroxyprogesterone acetate is available as a depot injection which is injected once every three months to provide continuous hormonal contraception and releases for up to nine months after injection.
Availability
Many medications are available as depot injections, including many typical and atypical antipsychotics,
as well as some
hormonal medications and medication for
opioid use disorder.
Depot injections of antipsychotics are used to improve historically low adherence in patients with diseases such as
schizophrenia
Schizophrenia () is a mental disorder characterized variously by hallucinations (typically, Auditory hallucination#Schizophrenia, hearing voices), delusions, thought disorder, disorganized thinking and behavior, and Reduced affect display, f ...
.
Different products may be administered or implanted either by a doctor or nurse, while some are designed to be administered by the patient themselves.
Self-administered depot injections are used to increase healthcare access and decrease the need to visit the doctor as frequently, especially in
low and middle income countries.
Insulin
Insulin (, from Latin ''insula'', 'island') is a peptide hormone produced by beta cells of the pancreatic islets encoded in humans by the insulin (''INS)'' gene. It is the main Anabolism, anabolic hormone of the body. It regulates the metabol ...
may also be considered a depot injection depending on formulation.
Insulin glargine
Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type 1 and type 2 diabetes. It is injected just under the skin. Effects generally begin an hour af ...
, for example, is designed to precipitate after injection so it can be slowly absorbed by the body over a longer period than
regular insulin would be. Depot injections of insulins have been studied to better replicate the body's natural
basal rate of insulin production, and which can be activated by light to control the release of insulin from the injected depot.
See also
*
Flip–flop kinetics
References
{{Dosage forms, state=expanded
Medical treatments
Routes of administration
Dosage forms
Injection (medicine)